Home › Esophageal Adenocarcinoma › Arizona
Esophageal Adenocarcinoma clinical trials in Arizona
10 studies for Esophageal Adenocarcinoma are looking for participants at sites in Arizona.
Cities in Arizona
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Kingman Regional Medical Center, Kingman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Mayo Clinic in Arizona - Phoenix, Phoenix
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07221149A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Phoenix, Goodyear
- Mayo Clinic Arizona, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Mayo Clinic, Scottsdale
Recruiting
Ages 18 to 89 · All sexes · Updated Sep 11, 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
- Mayo Clinic Arizona, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07431281Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Arizona Centers of Digestive Health, Gilbert
Recruiting
Ages 18 to 89 · All sexes · Updated Jul 1, 2026 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT07284186Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
- Mayo Clinic, Scottsdale
Recruiting
Ages 18 to 90 · All sexes · Updated Jun 2, 2026 · NCT06071845Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
- I-Mab Site 1016, Goodyear
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07432295From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.